Nyxoah S.A., a health-technology company, focuses on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. It offers Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treast moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is based in Mont-Saint-Guibert, Belgium. The company trades on NGM exchange. The company headquarter is located in Mont-Saint-Guibert ,Belgium.

TickerNYXH
Long NameNyxoah S.A.
Short NameNyxoah SA